MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021.
Looking for a particular MaaT Pharma employee's phone or email?
MaaT Pharma Questions
The MaaT Pharma annual revenue was $4 million in 2026.
Carole Schwintner is the CTO of MaaT Pharma.
64 people are employed at MaaT Pharma.
MaaT Pharma is based in Lyon, Auvergne-Rhone-Alpes.
The NAICS codes for MaaT Pharma are [511, 51121, 511210, 54, 51, 5112, 541].
The SIC codes for MaaT Pharma are [80, 87, 73, 737].
Top MaaT Pharma Employees
-
Eric Soyer
Chief Financial Officer at MaaT Pharma
Caluire-et-Cuire, FR21 -
Jonathan Chriqui
Chief Business Officer at MaaT Pharma
Île-de-France, France22 -
Carole Ifi
Head of Regulatory Affairs at MaaT Pharma
Rixensart, WAL, BE2
Related Companies
